Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109776422A reveals advanced copper-catalyzed asymmetric hydroboration for chiral alkyl borides, offering significant supply chain and cost advantages.
Advanced coupled synthesis technology for Vitamin B intermediates. Delivers high-purity Alpha-Acetyl-Gamma-Butyrolactone with optimized supply chain efficiency and cost reduction.
Patent CN110317189B reveals a novel TCCA-mediated chlorination route for 5-chlorothiophene-2-formic acid, offering significant cost reduction in API manufacturing and superior scalability.
Patent CN114805107A details a mild photocatalytic N-alpha arylation method. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity intermediates.
Novel single-chamber electrochemical method reduces cost and complexity for aziridine manufacturing, offering reliable supply chain solutions.
Patent CN101870703B details a novel disulfide porphyrin catalyst enabling efficient aerobic oxidation. Discover cost-effective manufacturing and supply chain advantages.
Patent CN108484461A reveals metal-free thioamide synthesis. Enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.
Patent CN114853707A details a novel photocatalytic route for difluoromethylated 2,3-dihydrobenzopyran-4-ones, offering safer reagents and commercial scalability for pharmaceutical intermediates.
Patent CN114751872A details a high-yield Pillar[5]arene N-heterocyclic carbene catalyst. Discover cost-effective synthesis and Stetter reaction applications.
Novel halogenation-fluorination route for 5-fluoro-2-hydroxyacetophenone. High yield, low waste, scalable process for beta-blocker intermediates.
Patent CN116121310A reveals a high-efficiency enzymatic route for dexketoprofen, offering superior purity and scalable production for reliable pharmaceutical intermediates suppliers.
Patent CN101701027B details a novel catalytic cracking method for nucleosides, offering high-yield production of tetraacetyl ribofuranose and acetylated purines for reliable pharmaceutical intermediates supply chains.
Discover the green one-pot synthesis of 16-dehydropregnenolone acetate using vanadium catalysis. A cost-effective, scalable solution for pharmaceutical intermediate manufacturing.
Patent CN111285768B introduces a recyclable polyionic liquid copper catalyst for efficient asymmetric Henry reactions in water, offering significant cost reduction in chiral catalyst manufacturing.
Patent CN112876507B details a Ru-catalyzed hydroarylation method for trisubstituted olefin phosphines, offering high yields up to 90% and reduced costs for pharma intermediates.
Patent CN115925609A details a green FeCl2-catalyzed route to 3-alkenyl oxindoles. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN102464672A discloses a novel mannitol-based ligand for asymmetric catalysis, offering high enantioselectivity and simplified synthesis for cost-effective pharmaceutical manufacturing.
Patent CN103553931A reveals a novel organocatalytic route for chiral diketones, delivering high enantioselectivity and yield for efficient steroid and terpenoid synthesis.
Novel iron-catalyzed route for oxazoline compounds ensures high purity and scalable production. Reduces operational complexity for pharmaceutical intermediate manufacturing supply chains globally.
Patent CN110903189B details a cost-effective copper-catalyzed route for chiral 2-aryl propionates, offering significant supply chain advantages for NSAID intermediate manufacturing.